Cited by 117Atherosclerosis and Cardiovascular DiseasesCoronary Interventions and DiagnosticsCerebrovascular and Carotid Artery Diseases

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization

Jain, Rakesh K, Finn, Aloke V, Kolodgie, Frank D, Gold, Herman K, Virmani, Renu·2007·Nature Clinical Practice Cardiovascular Medicine

DOI 10.1038/ncpcardio0979

Open this paper in CoChat — free account

Abstract

Angiogenesis within human atherosclerotic plaques has an important role in plaque progression as immature blood vessels leak red blood cells and inflammatory mediators into the plaque center. Accumulation of free cholesterol from red blood cell membranes potentially increases the size of the necrotic core and triggers a chain of events that promote plaque destabilization. Antiangiogenic agents have been shown to prune some tumor vessels and 'normalize' the structure and function of the remaining vasculature, thereby improving the access of chemotherapeutic agents to tumors. We propose that antiangiogenic therapy can similarly stabilize vulnerable 'rupture-prone' plaques by pruning and normalizing immature intraplaque vessels, preventing further intraplaque hemorrhage. This normalization would limit necrotic core enlargement, further luminal narrowing and the degree of inflammation. Such normalization has been realized using vascular endothelial growth factor antagonists for the treatment of cancer and age-related macular degeneration. The development of this novel approach to prevent plaque progression might add to the armamentarium of preventive measures for acute myocardial infarction, stroke and sudden cardiac death.

Integrity signals

Registry

Crossref · 10.1038/ncpcardio0979

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,857
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Self-citation
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“From Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.”
BackgroundSelf-citation
Lessons From Sudden Coronary Death: A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
Self-citation
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
Yang, J. C., Haworth, L. R., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,704
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594
Self-citation
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Self-citation
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,985
Self-citation
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Self-citation
Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly
BURKE, A. P., Farb, A. A., Malcom, G. T., Liang, Y.-H., Smialek, J. E., & Virmani, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361802 · Cited by 1,739
Self-citation
Intraplaque Hemorrhage and Progression of Coronary Atheroma
Kolodgie, F. D., Gold, H. K., BURKE, A. P., Fowler, D. R., Kruth, H. S., Weber, D. K., Farb, A. A., Guerrero, L. J., Hayase, M., Kutys, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035655 · Cited by 1,491
Self-citation
Atherosclerotic Plaque Progression and Vulnerability to Rupture
Virmani, R., Kolodgie, F. D., BURKE, A. P., Finn, A. V., Gold, H. K., Tulenko, T. N., Wrenn, S. P., & Narula, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000178991.71605.18 · Cited by 1,326
Self-citation
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L. M., Ferrara, N., King, G. L., & Smith, L. E. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,268
Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Self-citation
Immune mechanisms in atherosclerosis.
Hansson, G. K., Jonasson, L., Seifert, P. S., & Stemme, S. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.5.567 · Cited by 1,172
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Self-citation
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1
Luttun, A., Tjwa, M., Moons, L., Wu, Y. L., Angelillo‐Scherrer, A., Liao, F., Nagy, J. A., Hooper, A. T., Priller, J., Klerck, B. D., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,076
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,047
Self-citation
Healed Plaque Ruptures and Sudden Coronary Death
BURKE, A. P., Kolodgie, F. D., Farb, A. A., Weber, D. K., Malcom, G. T., Smialek, J. E., & Virmani, R. (2001) · Circulation · doi:10.1161/01.cir.103.7.934 · Cited by 922
Self-citation
Immune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 877
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
FERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina · doi:10.1097/01.iae.0000242842.14624.e7 · Cited by 849
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
Kamba, T., Tam, B. Y. Y., Hashizume, H., Haskell, A., Sennino, B., Mancuso, M. R., Norberg, S. M., O’Brien, S., Davis, R. B., Gowen, L. C., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00133.2005 · Cited by 788
Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts
Inai, T., Mancuso, M. R., Hashizume, H., Baffert, F., Haskell, A., Bałuk, P., Hu‐Lowe, D. D., Shalinsky, D. R., Thurston, G., Yancopoulos, G. D., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63273-7 · Cited by 769
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.
Shah, P. K., Falk, E., Badimón, J. J., Fernández‐Ortíz, A., Mailhac, A. C., Villareal-Levy, G., Fallon, J. T., Regnström, J., & Fuster, V. (1995) · PubMed · Cited by 722
Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice
Moulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688
Statins Have Biphasic Effects on Angiogenesis
Weis, M., Heeschen, C., Glassford, A. J., & Cooke, J. P. (2002) · Circulation · doi:10.1161/hc0602.103393 · Cited by 677
Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta
Moreno, P., Purushothaman, K., Fuster, V., Echeverri, D., Truszczynska, H., Sharma, S. K., Badimón, J. J., & O’Connor, W. N. (2004) · Circulation · doi:10.1161/01.cir.0000143233.87854.23 · Cited by 632
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis
Vlodavsky, I., & Friedmann, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13662 · Cited by 619
Neovascular Expression of E-Selectin, Intercellular Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Human Atherosclerosis and Their Relation to Intimal Leukocyte Content
O’Brien, K. D., McDonald, T. O., Chait, A., Allen, M. D., & Alpers, C. E. (1996) · Circulation · doi:10.1161/01.cir.93.4.672 · Cited by 573
Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques
Takaya, N., Yuan, C., Chu, B., Saam, T., Polissar, N. L., Jarvik, G. P., Isaac, C. A., McDonough, J., Natiello, C., Small, R., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.504167 · Cited by 562
The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide
Fung, A. E., Rosenfeld, P. J., & Reichel, E. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.099598 · Cited by 532
Neovascularization in Human Atherosclerosis
Moreno, P., Purushothaman, K., Sirol, M., Levy, A. P., & Fuster, V. (2006) · Circulation · doi:10.1161/circulationaha.105.578955 · Cited by 508
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition
Verheul, H. M. W., & Pinedo, H. M. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2152 · Cited by 506
Hemoglobin Scavenger Receptor CD163 Mediates Interleukin-10 Release and Heme Oxygenase-1 Synthesis: Antiinflammatory Monocyte-Macrophage Responses In Vitro, in Resolving Skin Blisters In Vivo, and After Cardiopulmonary Bypass Surgery
Philippidis, P., Mason, J. C., Evans, B. J., Nadra, I., Taylor, K. M., Haskard, D. O., & Landis, R. C. (2004) · Circulation Research · doi:10.1161/01.res.0000109414.78907.f9 · Cited by 476
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
Aliello, L. P. (1995) · Medical Entomology and Zoology · Cited by 463
The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions.
Gerrity, R. G. (1981) · PubMed · Cited by 459
Role of Angiogenesis in Cardiovascular Disease
Khurana, R., Simons, M., Martin, J. F., & Zachary, I. C. (2005) · Circulation · doi:10.1161/circulationaha.105.535294 · Cited by 459
Plaque Rupture and Sudden Death Related to Exertion in Men With Coronary Artery Disease
BURKE, A. P., Farb, A. A., Malcom, G. T., Liang, Y.-H., Smialek, J. E., & Virmani, R. (1999) · JAMA · doi:10.1001/jama.281.10.921 · Cited by 454
Self-citation
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
Darbonne, W. C., Rice, G. C., Möhler, M., Apple, T., Hébert, C. A., Valente, A. J., & Baker, J. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115442 · Cited by 452
During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium
Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., & Jain, R. K. (1996) · Nature Medicine · doi:10.1038/nm0996-992 · Cited by 451
Self-citation
Disruption of TGF-β signaling in T cells accelerates atherosclerosis
Robertson, A.-K. L., Rudling, M. J., Zhou, X., Gorelik, L., Flavell, R. A., & Hansson, G. K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18607 · Cited by 440
Surrogate Markers for Antiangiogenic Therapy and Dose-Limiting Toxicities for Bevacizumab With Radiation and Chemotherapy: Continued Experience of a Phase I Trial in Rectal Cancer Patients
Willett, C. G., Boucher, Y., Duda, D. G., di Tomaso, E., Munn, L. L., Tong, R. T., Kozin, S. V., Petit, L., Jain, R. K., Chung, D. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5635 · Cited by 420
Self-citation
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature
Guetz, G. D., Uzzan, B., Nicolas, P., Cucherat, M., Morère, J., Benamouzig, R., Breau, J. L., & Perret, G.-Y. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603176 · Cited by 406
Advanced Atherosclerotic Lesions in the Innominate Artery of the ApoE Knockout Mouse
Rosenfeld, M. E., Polinsky, P., Virmani, R., Kauser, K. Z., Rubanyi, G. M., & Schwartz, S. M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2587 · Cited by 384
Self-citation
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
Autiero, M., Luttun, A., Tjwa, M., & Carmeliet, P. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00263.x · Cited by 364
Arterial Neovascularization and Inflammation in Vulnerable Patients
Fleiner, M., Kummer, M., Mirlacher, M., Sauter, G., Cathomas, G., Krapf, R., & Biedermann, B. C. (2004) · Circulation · doi:10.1161/01.cir.0000146787.16297.e8 · Cited by 349
Unraveling the Reactions of Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics
Kim-Shapiro, D. B., Schechter, A. N., & Gladwin, M. T. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000204350.44226.9a · Cited by 308
Managing Patients Treated with Bevacizumab Combination Therapy
Gordon, M. S., & Cunningham, D. (2005) · Oncology · doi:10.1159/000088481 · Cited by 284
Plaque Rupture in Humans and Mice
Schwartz, S. M., Galis, Z. S., Rosenfeld, M. E., & Falk, E. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000261709.34878.20 · Cited by 257
Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma
Wang, N., Tabas, I. A., WINCHESTER, R. J., Stefano Ravalli, A., Rabbani, L. E., & Tall, A. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8837 · Cited by 252
CD163: a signal receptor scavenging haptoglobin–hemoglobin complexes from plasma
Graversen, J. H., Madsen, M. M., & Moestrup, S. K. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00144-3 · Cited by 245
Plaque Rupture After Short Periods of Fat Feeding in the Apolipoprotein E–Knockout Mouse
Johnson, J. L., Carson, K. G. S., Williams, H. J., Karanam, S., Newby, A. C., Angelini, G. D., George, S. J., & Jackson, C. L. (2005) · Circulation · doi:10.1161/01.cir.0000158435.98035.8d · Cited by 241
Regulation of CD163 on human macrophages: cross-linking of CD163 induces signaling and activation
van den Heuvel, M. M., Tensen, C. P., van As, J., van den Berg, T. K., Fluitsma, D. M., Dijkstra, C. D., Döpp, E. A., Droste, A., van Gaalen, F. A., Sorg, C., et al. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.858 · Cited by 222
Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis
Kockx, M. M., Cromheeke, K. M. C., Knaapen, M., Bosmans, J. M., Meyer, G. R. Y. D., Herman, A. G., & Bult, H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000057807.28754.7f · Cited by 218
The Mac-1 and p150,95 β2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion
Davis, G. E. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90170-d · Cited by 214
Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation
Muñoz-Nájar, U. M., Neurath, K. M., Vumbaca, F., & Claffey, K. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209273 · Cited by 209
Immunohistochemical study of intimal microvessels in coronary atherosclerosis.
Zhang, Y., Cliff, W. J., Schoefl, G. I., & Higgins, G. (1993) · PubMed Central · Cited by 200
Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels.
Kohn, S., Nagy, J. A., Dvorak, H. F., & Dvořàk, A. M. (1992) · PubMed · Cited by 190
Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques
Dunmore, B. J., McCarthy, M. J., Naylor, A. R., & Brindle, N. P. J. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.08.072 · Cited by 187
Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): BO17704
Manegold, C., von Pawel, J., Zatloukal, P., Ramlau, R., Gorbounova, V. A., Hirsch, V., Leighl, N. B., Mezger, J., Archer, V. R., & Reck, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.lba7514 · Cited by 168
Cutaneous malignant melanoma: Correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor
T[oacute]th, T. (2000) · Human Pathology · doi:10.1053/hupa.2000.16658 · Cited by 165
Ranibizumab for Neovascular Age-Related Macular Degeneration
Liew, G., & Mitchell, P. (2007) · New England Journal of Medicine · doi:10.1056/nejmc063011 · Cited by 156
Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque
Levy, A. P., Levy, J. E., Kalet-Litman, S., Miller‐Lotan, R., Levy, N. S., Asaf, R., Guetta, J., Yang, C., Purushothaman, K., Fuster, V., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251020.24399.a2 · Cited by 152
Cholesterol and phospholipid metabolism in macrophages
Tabas, I. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00146-3 · Cited by 143
Immunohistochemical Expression of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Atherosclerotic Intimas of Human Coronary Arteries
Chen, Y., Nakashima, Y., Tanaka, K.-I., Shiraishi, S., Nakagawa, K., & Sueishi, K. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.131 · Cited by 126
A Simple Method of Plaque Rupture Induction in Apolipoprotein E–Deficient Mice
Sasaki, T., Kuzuya, M., Nakamura, K., Cheng, X. W., Shibata, T., Sato, K., & Iguchi, A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000219687.71607.f7 · Cited by 120
Adventitial Mast Cells Connect With Sensory Nerve Fibers in Atherosclerotic Coronary Arteries
Laine, P., Naukkarinen, A., Heikkilä, L. J., Penttilä, A., & Kovanen, P. T. (2000) · Circulation · doi:10.1161/01.cir.101.14.1665 · Cited by 118
Evidence That the Initial Up-regulation of Phosphatidylcholine Biosynthesis in Free Cholesterol-loaded Macrophages Is an Adaptive Response That Prevents Cholesterol-induced Cellular Necrosis
Tabas, I. A., Marathe, S. V., Keesler, G. A., Beatini, N., & Shiratori, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22773 · Cited by 111
Mast Cells in Neovascularized Human Coronary Plaques Store and Secrete Basic Fibroblast Growth Factor, a Potent Angiogenic Mediator
Lappalainen, H., Laine, P., Pentikäinen, M. O., Sajantila, A., & Kovanen, P. T. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000140820.51174.8d · Cited by 104
Genentech discloses safety concerns over Avastin
Ratner, M. A. (2004) · Nature Biotechnology · doi:10.1038/nbt1004-1198 · Cited by 98
Carotid rupture and intraplaque hemorrhage: Immunophenotype and role of cells involved
Milei, J., Parodi, J. C., Alonso, G. F., Barone, A., Grana, D. R., & Matturri, L. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70169-3 · Cited by 96
Arterial thromboembolic events (ATEs) in a pooled analysis of 5 randomized, controlled trials (RCTs) of bevacizumab (BV) with chemotherapy
Skillings, J. R., Johnson, D. H., Miller, K. D., Kabbinavar, F. F., Bergsland, E. K., Holmgren, E. B., Holden, S. N., Hurwitz, H. I., & Scappaticci, F. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3019 · Cited by 95
Blood flow through vasa vasorum of coronary arteries in atherosclerotic monkeys.
Heistad, D. D., & Armstrong, M. L. (1986) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.6.3.326 · Cited by 92
Myocyte loss in chronic heart failure
Rayment, N. B., Haven, A. J., Madden, B. P., Murday, A. J., Trickey, R. J., Shipley, M. J., Davies, M. J., & Katz, D. R. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199906)188:2 · Cited by 57
When neoangiogenesis ricochets
Virmani, R., Narula, J., & Farb, A. A. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70144-9 · Cited by 54
Self-citation
Cardiovascular toxicity of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozotocin and bevacizumab.
Drimal, J., Zúrová-Nedelcevová, J., Knezl, V., Sotníková, R., & Navarová, J. (2006) · PubMed · Cited by 36
The significance of free blood in liquid and solid tumours.
van den Brenk, H. A., Crowe, M. C., Kelly, H. D. B., & Stone, M. G. (1977) · PubMed Central · Cited by 17

Sorted by citations

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,740
Self-citation
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Self-citation
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
Self-citation
Angiogenesis in brain tumours
Jain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2175 · Cited by 1,444
Self-citation
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248
Self-citation

See all 117

Authors: Jain, R. K., Finn, A. V., Kolodgie, F. D., Gold, H. K., & Virmani, R.
Affiliations: Harvard University (US)
CVPath Institute (US)
Corresponding author: Jain, Rakesh K
Gold, Herman K
ORCID: Finn, Aloke V
Kolodgie, Frank D
Virmani, Renu
Venue: Nature Clinical Practice Cardiovascular Medicine
Publisher: Springer Science and Business Media LLC
Published: 2007-09
Volume: 4
Issue: 9
Pages: 491-502
ISSN: 1743-4297 (ISSN-L)
1743-4300
DOI: 10.1038/ncpcardio0979
OpenAlex: W2024455227
Cited by: 117
References: 80
Citations by year: 2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 8 · 2017: 6 · 2016: 3 · 2015: 9 · 2014: 9 · 2013: 10 · 2012: 14
FWCI: 0.83
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Clinical Practice Cardiovascular Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P01CA080124)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
Keywords: anti-angiogenic therapy, atherosclerotic plaque, plaque stabilization, intraplaque hemorrhage, angiogenesis, vascular normalization, vulnerable plaque, necrotic core, plaque progression, acute myocardial infarction, stroke, sudden cardiac death
MeSH terms: Coronary Artery Disease, Coronary Vessels, Hemorrhage, Humans, Neovascularization, Pathologic, Angiogenesis Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks